Interleukin-10 controls the protective effects of circulating microparticles from patients with septic shock on tissue-engineered vascular media

Clinical Science

Volumn 125, Issue 2, 2013, Pages 77-85

  Mostefai, Hadj Ahmed ^a,b   Bourget, Jean Michel ^c   Meziani, Ferhat ^b,d,e,f,g   Martinez, Maria Carmen ^a,b   Leonetti, Daniela ^a,b,f   Mercat, Alain ^b,d,e   Asfar, Pierre ^b,d,e   Germain, Lucie ^c,d   Andriantsitohaina, Ramaroson ^a,b,f,g  

^a INSERM   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e UNIVERSITÉ D'ANGERS   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Inflammation; Microparticle; Nitric oxide; Oxidative stress; Sepsis; Shock

Indexed keywords

CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; SUPEROXIDE; IL10 PROTEIN, HUMAN; MESSENGER RNA;

AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SMOOTH MUSCLE FIBER; SURVIVAL; TISSUE ENGINEERING; TUNICA MEDIA; UMBILICAL CORD; ANIMAL; CYTOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEPSIS; SHOCK; UMBILICAL ARTERY; VASCULAR SMOOTH MUSCLE;

AGED; ANIMALS; CELL-DERIVED MICROPARTICLES; FEMALE; HISTAMINE; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MICE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; RNA, MESSENGER; SEPSIS; SHOCK; TISSUE ENGINEERING; UMBILICAL ARTERIES;

MLCS; MLOWN;

EID: 84878075738     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120441     Document Type: Article

References (24)

1. Hotchkiss, R. S. and Karl, I. E. (2003) The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348, 138-150
2. Parrillo, J. E. (1999) Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328, 1471-1477
3. Court, O., Kumar, A., Parrillo, J. E. and Kumar, A. (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit. Care 6, 500-508
4. Tual-Chalot, S., Leonetti, D., Andriantsitohaina, R. and Mart́i{dotless}nez, M. C. (2011) Microvesicles: intercellular vectors of biological messages. Mol. Interv. 11, 88-94
5. Martinez, M. C., Tual-Chalot, S., Leonetti, D. and Andriantsitohaina, R. (2011) Microparticles: targets and tools in cardiovascular disease. Trends Pharmacol. Sci. 32, 659-665
6. Mostefai, H. A., Meziani, F., Mastronardi, M. L., Agouni, A., Heymes, C., Asfar, P., Martinez, M. C. and Andriantsitohaina, R. (2008) Circulating microparticles from patients with septic shock exert protective role in vascular function. Am. J. Respir. Crit. Care Med. 178, 1148-1155
7. Stoclet, J. C., Martinez, M. C., Ohlmann, P., Chasserot, S., Schott, C., Kleschyov, A. L., Schneider, F. and Andriantsitohaina, R. (1999) Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. Circulation 100, 107-112
8. Pricci, M., Bourget, J. M., Robitaille, H., Porro, C., Soleti, R., Mostefai, H. A., Auger, F. A., Martinez, M. C., Andriantsitohaina, R. and Germain, L. (2009) Applications of human tissue-engineered blood vessel models to study the effects of shed membrane microparticles from T-lymphocytes on vascular function. Tissue Eng. Part A 15, 137-145
9. Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J. L. and Ramsay, G. (2003) 2001 SCCM/ESIC/ACCP/ATS/SIS International sepsis definitions conference. Crit. Care Med. 31, 1250-1256
10. L'Heureux, N., Stoclet, J. C., Auger, F. A., Lagaud, G. J., Germain, L. and Andriantsitohaina, R. (2001) A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J. 15, 515-524
11. Laflamme, K., Roberge, C. J., Grenier, G., Ŕemy-Zolghadri, M., Pouliot, S., Baker, K., Labb́e, R., D'Orĺeans-Juste, P., Auger, F. A. and Germain, L. (2006) Adventitia contribution in vascular tone: insights from adventitia-derived cells in a tissue-engineered human blood vessel. FASEB J. 20, 1245-1247
12. Mastronardi, M. L., Mostefai, H. A., Meziani, F., Martinez, M. C., Asfar, P. and Andriantsitohaina, R. (2011) Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit. Care Med. 39, 1739-1748
13. Rozen, S. and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology (Krawetz, S. and Misener, S., eds), pp. 365-386, Humana Press, Totowa, NJ
14. Vandesompele, J., De Paepe, A. and Speleman, F. (2002) Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal. Biochem. 303, 95-98
15. Diebolt, M., Laflamme, K., Labb́e, R., Auger, F. A., Germain, L. and Andriantsitohaina, R. (2007) Polyphenols modulate calcium-independent mechanisms in human arterial tissue-engineered vascular media. J. Vasc. Surg. 46, 764-772
16. Laflamme, K., Roberge, C. J., Pouliot, S., D'Orĺeeans-Juste, P., Auger, F. A. and Germain, L. (2006) Tissue-engineered human vascular media produced in vitro by the self-assembly approach present functional properties similar to those of their native blood vessels. Tissue Eng. 12, 2275-2281
17. Mortaza, S., Martinez, M. C., Baron-Menguy, C., Burban, M., de la Bourdonnaye, M., Fizanne, L., Pierrot, M., Cal'es, P., Henrion, D., Andriantsitohaina, R. et al. (2009) Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit. Care Med. 37, 2045-2050
18. Gunnett, C. A., Berg, D. J., Faraci, F. M. and Feuerstein, G. (1999) Vascular effects of lipopolysaccharide are enhanced in interleukin-10-deficient mice. Stroke 30, 2191-2195
19. Gunnett, C. A., Heistad, D. D., Berg, D. J. and Faraci, F. M. (2000) IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. Heart Circ. Physiol. 279, H1555-H1562
20. Gunnett, C. A., Heistad, D. D. and Faraci, F. M. (2002) Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. Diabetes 51, 1931-1937
21. Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G. and Simmons, R. L. (1992) Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257, 387-389
22. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. and O'Garra, A. (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451
23. Florquin, S., Amraoui, Z., Abramowicz, D. and Goldman, M. (1994) Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J. Immunol. 153, 2618-2623
24. Moncada, S., Palmer, R. M. and Higgs, E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142